BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TETHYS BIOSCIENCE — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

TETHYS BIOSCIENCE

via FOLEY HOAG LLP

1st Quarter (Jan 1 - Mar 31) · 2010Posted Apr 21, 2010Filing document ↗LDA record ↗

Income$15Kfee reported

Client

Name: TETHYS BIOSCIENCE
Description: Discovers, develops, and creates novel biological markers
Location: * Undetermined

Registrant

Firm: FOLEY HOAG LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Medicare Payment for Diabetes screening; Healthcare Reform and Prevention
LobbyistsBRIAN CAREY · SUSIE AHN · MAIA LARSSON
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.